Dynamics of HIV prevalence among pregnant women in Ukraine in 2016-2024: regional analysis
DOI:
https://doi.org/10.15574/HW.2025.5(180).2126Keywords:
HIV infection, pregnant women, prevalence, epidemiology, regional analysis, Ukraine, Public Health Center of the Ministry of Health of UkraineAbstract
HIV infection remains an urgent medical and social problem and a significant challenge for the public health system. Monitoring the prevalence of HIV among pregnant women is of particular importance, as this indicator reflects the intensity of the epidemic process among women of reproductive age and the effectiveness of vertical transmission prevention programs. In Ukraine, the epidemiological situation is characterized by pronounced regional heterogeneity.
Aim - to analyze the dynamics and regional characteristics of the prevalence of HIV among pregnant women in Ukraine in 2016-2024.
Materials and methods. A retrospective descriptive epidemiological study was conducted based on the official statistical data of the Public Health Center of the Ministry of Health of Ukraine regarding the number of HIV-positive pregnant women registered in Ukraine and its regions in 2016-2024. The absolute indicators and their share in the national structure (%) were analyzed. A comparative analysis of the dynamics by years and regions was carried out with the determination of trends, structural changes and territorial differences. Methods of descriptive statistics were used.
Results. During the studied period, a steady trend towards a decrease in the number of HIV-positive pregnant women was established: from 2,814 cases in 2016 to 1,083 in 2024, which is a decrease of 61.5%. The most pronounced reduction was noted after 2021. During the entire period, the highest absolute indicators were registered in the Dnipropetrovsk and Odesa regions. In 2024, their share was 15.6% and 17.0% of the total number of cases in Ukraine, respectively. A significant decrease in indicators was observed in the Donetsk, Zaporizhzhia and Kherson regions after 2021. The western regions were characterized by relatively low and stable indicators. Despite the overall decrease in the number of cases, regional disparities persist.
Conclusions. In 2016-2024, a consistent decrease in the prevalence of HIV among pregnant women was noted in Ukraine. At the same time, significant regional unevenness remains, with the concentration of most cases in the southern and eastern regions. The sharp decrease in rates after 2021 needs to be interpreted with caution, taking into account possible changes in the availability of medical care and the completeness of case registration. Further epidemiological monitoring and strengthening of programs for the prevention of vertical transmission of HIV are necessary.
The authors declare no conflict of interest.
References
Atowoju I, Dawer P, Asrani M, Panjiyar B. (2024, Jul). Impact of maternal HIV infection on perinatal outcomes: A systematic review. Int J Gynaecol Obstet. 166(1): 35-43. https://doi.org/10.1002/ijgo.15528; PMid:38573155
De Waard L, Langenegger E, Erasmus K, Van der Merwe T, Olivier SE, Du Toit N et al. (2021, Dec 2). Maternal and neonatal outcomes of COVID-19 in a high-risk pregnant cohort with and without HIV. S Afr Med J. 111(12): 1174-1180. https://doi.org/10.7196/SAMJ.2021.v111i12.15683; PMid:34949304
Dude AM, Jones M, Wilson T. (2023, Jun). Human Immunodeficiency Virus in Pregnancy. Obstet Gynecol Clin North Am. 50(2): 389-399. https://doi.org/10.1016/j.ogc.2023.02.010; PMid:37149318
Gutema G, Tola HH, Fikadu D, Leta D, Bejiga B, Tura JB et al. (2023, Jun 6). Positivity rate, trend and associated risk factors of mother-to-child transmission of HIV among HIV-exposed infants. BMC Pediatr. 23(1): 283. https://doi.org/10.1186/s12887-023-04074-2; PMid:37280581 PMCid:PMC10245613
Karthigeyan KP, Binuya C, Vuong K, Permar SR, Nelson AN. (2024, Dec). Research on Maternal Vaccination for HIV Prevention. Clin Perinatol. 51(4): 769-782. https://doi.org/10.1016/j.clp.2024.08.007; PMid:39487019 PMCid:PMC11531644
Kumar N, Mangla M. (2022, Apr 1). Influence of paired pandemic of COVID-19 and HIV infection on pregnant women and children: A challenging issue. J Mother Child. 25(2): 123-126. doi: 10.34763/jmotherandchild.20212502.d-21-00017.
Lopes BB, Ramalho AKL, Oriá MOB, Cunha GHD, Aquino PS, Pinheiro AKB. (2023, Mar 27). Epidemiology of HIV in pregnant women and its relationship with the period of the COVID-19 pandemic. Rev Esc Enferm USP. 57: e20220339. https://doi.org/10.1590/1980-220x-reeusp-2022-0339en; PMid:36972324 PMCid:PMC10081587
Papadopoulos A, Thomas K, Protopapas K, Antonyak S, Begovac J, Dragovic G et al. (2023, Apr). HIV treatment strategies across Central, Eastern and Southeastern Europe: New times, old problems. HIV Med. 24(4): 462-470. https://doi.org/10.1111/hiv.13416; PMid:36196025
Ranzani A, Lapadula G, D'Aloia F, Ornaghi S, Locatelli A et al. (2025, Oct). Pregnancy in women living with HIV: Experience of IRCCS San Gerardo dei Tintori and a narrative review. New Microbiol. 48(3): 215-225.
Trindade LNM, Nogueira LMV, Rodrigues ILA, Guimarães RJPSE, Souza MHDN. (2023, Nov 20). Human immunodeficiency virus infection in pregnant women and its correlation with socioeconomic determinants. Rev Esc Enferm USP. 57: e20220321. https://doi.org/10.1590/1980-220x-reeusp-2022-0321en; PMid:37997877 PMCid:PMC10672042
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Ukrainian Journal Health of Woman

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The policy of the Journal UKRAINIAN JOURNAL «HEALTH OF WOMAN» is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license (СС BY-NC).
Authors transfer the copyright to the Journal UKRAINIAN JOURNAL «HEALTH OF WOMAN» when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.